NASDAQ · Financial Statements

CASI Pharmaceuticals, Inc. (CASI) Financial Statements

$0.15 NASDAQ: CASI Market Cap $2.33M

CASI Pharmaceuticals, Inc. most recently reported annual revenue of $29.0M, net profit of $-39.0M, revenue has compounded at 48.6% a year over the last five years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric20202021202220232024
Revenue$15.0M$30.0M$43.0M$34.0M$29.0M
Operating Profit$-53.0M$-42.0M$-26.0M$-25.0M$-40.0M
Net Profit$-48.0M$-37.0M$-41.0M$-27.0M$-39.0M
EPS$-4.37$-2.69$-3.01$-2.02$-2.56
Op Margin-348.6%-137.6%-61.5%-74.0%-138.8%

Balance Sheet (USD)

Metric20202021202220232024
Total Assets$128.0M$138.0M$96.0M$75.0M$54.0M
Total Liabilities$24.0M$30.0M$29.0M$51.0M$52.0M
Cash$57.0M$39.0M$47.0M$17.0M$13.0M
Borrowings$3.0M$4.0M$1.0M$21.0M$22.0M

Cash Flow (USD)

Metric20202021202220232024
Operating Cash Flow$-26.0M$-27.0M$-21.0M$-20.0M$-29.0M
Investing Cash Flow$-40.0M$-36.0M$26.0M$-12.0M$11.0M
Financing Cash Flow$1.0M$-2.0M$-3.0M$0$1.0M
Net Cash Flow$3.0M$-18.0M$8.0M$-30.0M$-4.0M
Free Cash Flow$-45.0M$-42.0M$-27.0M$-22.0M$-29.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-0.54
FCF Yield0.00%
Quick Ratio0.24
Interest Coverage-50.60
Return 1Y—
Return 3Y—
Return 5Y—

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
CASI Overview CASI Dividend Run Stock Screener